EUVIMEDEUVIMED entdecken
Open Access

Rapid and accurate remethylation of DNA in Dnmt3a- deficient hematopoietic cells with restoration of DNMT3A activity

Yang Li iD, Haley J Abel iD, Michelle Cai iD, Taylor A LaValle iD, Tiankai Yin iD, Nichole M Helton iD, Amanda M Smith iD, Christopher A Miller iD, Timothy J Ley iD

Science Advances · 2024

DOI: 10.1126/sciadv.adk8598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Yang Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section of Stem Cell Biology, Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA. Hauptthemen laut MEDLINE: DNA (Cytosine-5-)-Methyltransferases, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Here, we characterize the DNA methylation phenotypes of bone marrow cells from mice with hematopoietic deficiency of Dnmt3a or Dnmt3b (or both enzymes) or expressing the dominant-negative Dnmt3a R878H mutation [R882H in humans; the most common DNMT3A mutation found in acute myeloid leukemia (AML)]. Using these cells as substrates, we defined DNA remethylation after overexpressing wild-type (WT) DNMT3A1, DNMT3B1, DNMT3B3 (an inactive splice isoform of DNMT3B), or DNMT3L (a catalytically inactive “chaperone” for DNMT3A and DNMT3B in early embryogenesis). Overexpression of DNMT3A for 2 weeks reverses the hypomethylation phenotype of Dnmt3a-deficient cells or cells expressing the R878H mutation. Overexpression of DNMT3L (which is minimally expressed in AML cells) also corrects the hypomethylation phenotype of Dnmt3a R878H/+ marrow, probably by augmenting the activity of WT DNMT3A encoded by the residual WT allele. DNMT3L reactivation may represent a previously unidentified approach for restoring DNMT3A activity in hematopoietic cells with reduced DNMT3A function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA (Cytosine-5-)-MethyltransferasesLeukemia, Myeloid, AcuteHumansMiceAnimalsDNA Methyltransferase 3ADNAMutationDNA Methylation

Substanzen

DNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADNA

Autor:innen und Institutionen

  • Section of Stem Cell Biology, Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA.

ORCID-Profile: Yang Li, Haley J Abel, Michelle Cai, Taylor A LaValle, Tiankai Yin, Nichole M Helton, Amanda M Smith, Christopher A Miller, Timothy J Ley

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Li, Y., Abel, H. J., Cai, M., LaValle, T. A., Yin, T., Helton, N. M., Smith, A. M., Miller, C. A., & Ley, T. J. (2024). Rapid and accurate remethylation of DNA in Dnmt3a- deficient hematopoietic cells with restoration of DNMT3A activity. Science Advances. https://doi.org/10.1126/sciadv.adk8598

Vancouver

Li Y, Abel HJ, Cai M, LaValle TA, Yin T, Helton NM, et al. Rapid and accurate remethylation of DNA in Dnmt3a- deficient hematopoietic cells with restoration of DNMT3A activity. Science Advances. 2024. doi:10.1126/sciadv.adk8598

BibTeX
@article{Li2024,
  author = {Li, Yang and Abel, Haley J and Cai, Michelle and LaValle, Taylor A and Yin, Tiankai and Helton, Nichole M and Smith, Amanda M and Miller, Christopher A and Ley, Timothy J},
  title = {Rapid and accurate remethylation of DNA in Dnmt3a- deficient hematopoietic cells with restoration of DNMT3A activity},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adk8598}
}
Kostenlos starten →